Alcohol use disorder in the COVID-19 era: Position paper of the Italian Society on Alcohol (SIA).
Alcoholics Anonymous
Alcoholism
/ epidemiology
Ambulatory Care
/ organization & administration
COVID-19
/ epidemiology
COVID-19 Vaccines
/ therapeutic use
Communicable Disease Control
Delivery of Health Care
/ organization & administration
Disease Susceptibility
Drug Interactions
Humans
Immunosuppression Therapy
/ adverse effects
Italy
/ epidemiology
Liver Cirrhosis, Alcoholic
/ epidemiology
Liver Transplantation
Recurrence
SARS-CoV-2
Societies, Medical
Telemedicine
COVID-19 Drug Treatment
COVID-19 infection
alcohol use disorder
drug interactions
infections
telemedicine
Journal
Addiction biology
ISSN: 1369-1600
Titre abrégé: Addict Biol
Pays: United States
ID NLM: 9604935
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
revised:
28
07
2021
received:
08
06
2020
accepted:
29
07
2021
pubmed:
18
9
2021
medline:
7
1
2022
entrez:
17
9
2021
Statut:
ppublish
Résumé
Coronavirus disease 2019 (COVID-19) first emerged in China in November 2019. Most governments have responded to the COVID-19 pandemic by imposing a lockdown. Some evidence suggests that a period of isolation might have led to a spike in alcohol misuse, and in the case of patients with alcohol use disorder (AUD), social isolation can favour lapse and relapse. The aim of our position paper is to provide specialists in the alcohol addiction field, in psychopharmacology, gastroenterology and in internal medicine, with appropriate tools to better manage patients with AUD and COVID-19,considering some important topics: (a) the susceptibility of AUD patients to infection; (b) the pharmacological interaction between medications used to treat AUD and to treat COVID-19; (c) the reorganization of the Centre for Alcohol Addiction Treatment for the management of AUD patients in the COVID-19 era (group activities, telemedicine, outpatients treatment, alcohol-related liver disease and liver transplantation, collecting samples); (d) AUD and SARS-CoV-2 vaccination. Telemedicine/telehealth will undoubtedly be useful/practical tools even though it remains at an elementary level; the contribution of the family and of caregivers in the management of AUD patients will play a significant role; the multidisciplinary intervention involving experts in the treatment of AUD with specialists in the treatment of COVID-19 disease will need implementation. Thus, the COVID-19 pandemic is rapidly leading addiction specialists towards a new governance scenario of AUD, which necessarily needs an in-depth reconsideration, focusing attention on a safe approach in combination with the efficacy of treatment.
Identifiants
pubmed: 34532923
doi: 10.1111/adb.13090
pmc: PMC8646667
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13090Informations de copyright
© 2021 The Authors. Addiction Biology published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.
Références
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Lancet Public Health. 2020 May;5(5):e259
pubmed: 32277874
J Dig Dis. 2020 Mar;21(3):125-126
pubmed: 32096611
Prev Med. 2019 Jun;123:65-70
pubmed: 30844499
Alcohol Res. 2015;37(2):185-97
pubmed: 26695744
Pharmacol Res. 2018 Jul;133:65-76
pubmed: 29719204
Ann Intern Med. 2020 Jul 7;173(1):61-62
pubmed: 32240293
Dig Liver Dis. 2020 Jan;52(1):21-32
pubmed: 31757596
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
N Engl J Med. 2021 Feb 11;384(6):497-511
pubmed: 33264556
J Gen Intern Med. 2020 May;35(5):1545-1549
pubmed: 32133578
Alcohol. 2011 Sep;45(6):523-39
pubmed: 21827928
Clin Exp Med. 2021 May;21(2):167-179
pubmed: 33128197
Lancet Public Health. 2020 May;5(5):e258
pubmed: 32247328
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
Lancet. 2019 Aug 31;394(10200):781-792
pubmed: 31478502
N Engl J Med. 2021 Jun 10;384(23):2187-2201
pubmed: 33882225
Drug Discov Ther. 2020;14(1):58-60
pubmed: 32147628
Brain Behav Immun. 2020 Jul;87:184-187
pubmed: 32454138
Clin Microbiol Rev. 2019 Mar 13;32(2):
pubmed: 30867162
SN Compr Clin Med. 2020;2(12):2637-2646
pubmed: 33163859
Intern Emerg Med. 2020 Nov;15(8):1507-1515
pubmed: 32979193
N Engl J Med. 2021 Jan 14;384(2):e6
pubmed: 33378604
J Hepatol. 2020 Nov;73(5):1063-1071
pubmed: 32526252
Clin Toxicol (Phila). 2006;44(2):173-5
pubmed: 16615675
JAMA Cardiol. 2020 Sep 01;5(9):1036-1041
pubmed: 32936252
BMJ Open. 2018 Aug 22;8(8):e022344
pubmed: 30135186
N Engl J Med. 2012 Nov 8;367(19):1814-20
pubmed: 23075143
Asian J Psychiatr. 2020 Jun;51:102092
pubmed: 32315963
Hepatology. 2020 Jul;72(1):287-304
pubmed: 32298473
J Microbiol Biotechnol. 2020 Mar 28;30(3):313-324
pubmed: 32238757
Liver Int. 2018 Feb;38 Suppl 1:126-133
pubmed: 29427501
PLoS Pathog. 2017 Jun 12;13(6):e1006426
pubmed: 28604843
Expert Rev Clin Pharmacol. 2021 Jan;14(1):95-103
pubmed: 33252992
Clin Pharmacol Ther. 2020 Oct;108(4):791-797
pubmed: 32324898
Expert Opin Ther Pat. 2021 Apr;31(4):295-307
pubmed: 33283567
Psychosomatics. 2018 Mar - Apr;59(2):105-122
pubmed: 29275963
Drug Saf. 2008;31(10):851-65
pubmed: 18759509
JAMA. 2020 Jun 23;323(24):2493-2502
pubmed: 32392282
Alcohol Alcohol. 2008 Nov-Dec;43(6):706-12
pubmed: 18790829
Eur Neuropsychopharmacol. 2014 Feb;24(2):181-91
pubmed: 24182622
Minerva Med. 2021 Dec;112(6):692-694
pubmed: 34142785
Cochrane Database Syst Rev. 2017 Sep 25;9:CD011479
pubmed: 28944453
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
JAMA Netw Open. 2019 Jun 5;2(6):e195172
pubmed: 31173120
Respir Med. 2014 Jan;108(1):114-21
pubmed: 24064346
Gastroenterology. 2020 May;158(6):1518-1519
pubmed: 32142785
Lancet. 2018 Sep 22;392(10152):1015-1035
pubmed: 30146330
Alcohol. 2015 Feb;49(1):57-64
pubmed: 25572859
Am J Psychiatry. 2020 Sep 1;177(9):805-807
pubmed: 32660296
J Subst Abuse Treat. 2019 Jun;101:38-49
pubmed: 31006553
JHEP Rep. 2020 Jun;2(3):100113
pubmed: 32289115
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Gastroenterology. 1994 Jun;106(6):1724-6
pubmed: 8194729
Dig Liver Dis. 2020 Apr;52(4):374-391
pubmed: 32001151
Addict Biol. 2022 Jan;27(1):e13090
pubmed: 34532923
J Leukoc Biol. 2009 Nov;86(5):1097-104
pubmed: 19602670
J Med Internet Res. 2020 Jan 31;22(1):e13252
pubmed: 32012048
Dig Liver Dis. 2020 Sep;52(9):956-957
pubmed: 32513630
JHEP Rep. 2020 Oct;2(5):100169
pubmed: 32835190
J Hepatol. 2020 Sep;73(3):705-708
pubmed: 32446714
Minerva Med. 2020 Feb;111(1):1-3
pubmed: 31359740
Am J Transplant. 2020 Jul;20(7):1773-1779
pubmed: 32202064
Lancet Psychiatry. 2019 Dec;6(12):1068-1080
pubmed: 31630984
J Telemed Telecare. 2020 Jun;26(5):309-313
pubmed: 32196391
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
N Engl J Med. 2003 Dec 18;349(25):2431-41
pubmed: 14681510
Minerva Gastroenterol Dietol. 2020 Jun;66(2):90-92
pubmed: 32221278
JAMA Psychiatry. 2015 Aug;72(8):757-66
pubmed: 26039070
Hepatology. 2020 Sep;72(3):1102-1108
pubmed: 32369624